Public health and international drug policy

J Csete, A Kamarulzaman, M Kazatchkine, F Altice… - The Lancet, 2016 - thelancet.com
Executive summary In September, 2015, the member states of the UN endorsed Sustainable
Development Goals (SDGs) for 2030, which aspire to human-rights-centred approaches to …

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review …

L Platt, S Minozzi, J Reed, P Vickerman, H Hagan… - …, 2018 - Wiley Online Library
Aims To estimate the effects of needle and syringe programmes (NSP) and opioid
substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C …

Medication-assisted treatment of opioid use disorder: review of the evidence and future directions

HS Connery - Harvard review of psychiatry, 2015 - journals.lww.com
Learning Objective: After participating in this activity, learners should be better able to:
Evaluate the rationale for and current evidence supporting medication-assisted treatment of …

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

L Platt, S Minozzi, J Reed, P Vickerman… - Cochrane Database …, 2017 - cochranelibrary.com
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C
transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library Skip to Content …

Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies

S Franchi, G Moschetti, G Amodeo… - Frontiers in …, 2019 - frontiersin.org
Suppression of the immune system has been constantly reported in the last years as a
classical side effect of opioid drugs. Most of the studies on the immunological properties of …

Elimination of HCV as a public health concern among people who inject drugs by 2030–What will it take to get there?

J Grebely, GJ Dore, S Morin… - African Journal of …, 2017 - journals.lww.com
Elimination of HCV as a public health concern among people w... : African Journal of
Reproduction and Gynaecological Endoscopy Elimination of HCV as a public health concern …

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

J Grebely, B Hajarizadeh, GJ Dore - Nature reviews Gastroenterology & …, 2017 - nature.com
Globally, 12 million people are estimated to have injected drugs in the past year, 50% of
whom have chronic HCV infection, with people who have previously injected drugs …

Recommendations for the management of hepatitis C virus infection among people who inject drugs

J Grebely, G Robaeys, P Bruggmann, A Aghemo… - International Journal of …, 2015 - Elsevier
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …

Intensive models of hepatitis C care for people who inject drugs receiving opioid agonist therapy: a randomized controlled trial

MJ Akiyama, BL Norton, JH Arnsten… - Annals of internal …, 2019 - acpjournals.org
Background: Many people who inject drugs (PWID) are denied treatment for hepatitis C virus
(HCV) infection, even if they are receiving opioid agonist therapy (OAT). Research suggests …

Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine

JI Tsui, J Mayfield, EC Speaker, S Yakup, R Ries… - Journal of Substance …, 2020 - Elsevier
Background Methamphetamine use is increasing in parts of the US, yet its impact on
treatment for opioid use disorder is relatively unknown. Methods The study utilized data on …